Celleron: The sound of silence

Emerging Company Profile

Many companies are trying to discover and validate biomarkers to help select the right patient populations for clinical trials. Celleron Therapeutics Ltd. is developing a cell-based functional screening platform that it believes will produce more accurate markers early in development than conventional statistical approaches that don’t provide insight into a marker’s functional relevance. The company is applying the platform to its own drug pipeline and plans to make it available for licensing...